Tarl Prow

Dr. Tarl Prow


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
TPTarl Prow
Tarl Prow
JGJeffrey Grice
Jeffrey Grice
LLLynlee L. Lin
Lynlee L. Lin
RFRokhaya Faye
Rokhaya Faye
MBMargaret Butler
Margaret Butler
Michael RobertsMichael Roberts
Michael Roberts

1 July 2018 in Cancer Cell
Verified
Journal Article
Closed access
ASA. Hunter Shain
A. Hunter Shain
NJNancy M. Joseph
Nancy M. Joseph
RYRichard Yu
Richard Yu
JBJamal Benhamida
Jamal Benhamida
SLShanshan Liu
Shanshan Liu
BBBoris C. Bastian
Boris C. Bastian

17 December 2014 in WIREs Nanomedicine and Nanobiotechnology
Verified
Journal Article
Open access
PDF file
MYMiko Yamada
Miko Yamada
MFMatthew Foote
Matthew Foote
TPTarl Prow
Tarl Prow
There are an abundance of nanoparticle technologies being developed for use as part of therapeutic strategies. This review focuses on a narrow class of metal nanoparticles that have therapeutic potential that is a consequence of elemental composition and size. The most widely known of these are gold nanoshells that have been developed over the last two decades for photothermal ablation in superficial cancers. The therapeutic effect is the outcome of the thickness and diameter of the gold shell that enables fine tuning of the plasmon resonance. When these metal nanoparticles are exposed to the relevant wavelength of light, their temperature rapidly increases. This in turn induces a localized photothermal ablation that kills the surrounding tumor tissue. Similarly, gold nanoparticles have been developed to enhance radiotherapy. The high‐Z nature of gold dramatically increases the photoelectric cross‐section. Thus, the photoelectric effects are significantly increased. The outcome of these interactions is enhanced tumor killing with lower doses of radiation, all while sparing tissue without gold nanoparticles. Silver nanoparticles have been used for their wound healing properties in addition to enhancing the tumor‐killing effects of anticancer drugs. Finally, platinum nanoparticles are thought to serve as a reservoir for platinum ions that can induce DNA damage in cancer cells. The future is bright with the path to clinical trials is largely cleared for some of the less complex therapeutic metal nanoparticle systems. WIREs Nanomed Nanobiotechnol 2015, 7:428–445. doi: 10.1002/wnan.1322This article is categorized under: Implantable Materials and Surgical Technologies > Nanomaterials and Implants Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Implantable Materials and Surgical Technologies > Nanoscale Tools and Techniques in Surgery

1 November 2009 in Journal of Controlled Release
Verified
Journal Article
Closed access
XCXianfeng Chen
Xianfeng Chen
TPTarl Prow
Tarl Prow
MCMichael Crichton
Michael Crichton
DJDerek W.K. Jenkins
Derek W.K. Jenkins
Michael RobertsMichael Roberts
Michael Roberts
MKMark A.F. Kendall
Mark A.F. Kendall

1 April 2011 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Michael RobertsMichael Roberts
Michael Roberts
YDYuri Dancik
Yuri Dancik
TPTarl Prow
Tarl Prow
CTCamilla A. Thorling
Camilla A. Thorling
LLLynlee L. Lin
Lynlee L. Lin
WBWolfgang Becker
Wolfgang Becker

27 July 2010 in Small
Verified
Journal Article
Closed access
PDF file
TPTarl Prow
Tarl Prow
XCXianfeng Chen
Xianfeng Chen
NPNatalie Prow
Natalie Prow
Germain J FernandoGermain J Fernando
Germain J Fernando
CTCindy S. E. Tan
Cindy S. E. Tan
MKMark A. F. Kendall
Mark A. F. Kendall